Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)

SHA:603456 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,981	21,777	35,397	46,842	28,827	11,231
Market Cap Growth	-45.10%	-38.48%	-24.43%	62.49%	156.68%	119.12%
Enterprise Value	10,889	18,935	34,444	46,532	29,243	11,002
Last Close Price	14.50	23.31	40.24	53.11	33.64	13.01
PE Ratio	18.74	21.08	38.43	73.90	75.75	47.23
Forward PE	15.76	33.52	33.52	33.52	33.52	33.52
PS Ratio	2.66	3.94	6.50	11.53	10.89	5.57
PB Ratio	1.53	2.55	6.59	10.23	9.34	3.93
P/TBV Ratio	1.80	2.78	7.48	11.44	10.40	4.49
P/FCF Ratio	50.54	69.14	479.75	340.48	48.06
P/OCF Ratio	16.47	16.01	28.88	69.14	72.00	20.27
EV/Sales Ratio	2.22	3.43	6.33	11.45	11.05	5.46
EV/EBITDA Ratio	9.68	12.86	25.17	45.74	40.68	22.84
EV/EBIT Ratio	14.91	17.17	33.58	64.10	62.67	37.84
EV/FCF Ratio	-56.67	43.95	67.28	476.58	345.39	47.07
Debt / Equity Ratio	0.06	0.05	0.07	0.15	0.30	0.31
Debt / EBITDA Ratio	0.45	0.28	0.26	0.69	1.31	1.81
Debt / FCF Ratio	-	0.96	0.69	7.22	11.08	3.73
Asset Turnover	0.44	0.59	0.73	0.68	0.55	0.51
Inventory Turnover	1.76	1.77	1.96	1.93	1.69	1.95
Quick Ratio	2.37	2.54	0.84	0.96	0.64	0.96
Current Ratio	3.65	3.81	1.80	1.81	1.41	1.69
Return on Equity (ROE)	8.19%	14.84%	18.51%	16.55%	12.78%	8.41%
Return on Assets (ROA)	4.09%	7.34%	8.58%	7.54%	6.03%	4.56%
Return on Capital (ROIC)	4.91%	9.40%	11.65%	9.75%	7.52%	5.56%
Return on Capital Employed (ROCE)	7.80%	12.00%	18.00%	14.60%	13.90%	8.40%
Earnings Yield	5.37%	4.75%	2.60%	1.35%	1.32%	2.12%
FCF Yield	-1.48%	1.98%	1.45%	0.21%	0.29%	2.08%
Dividend Yield	3.47%	2.15%	0.99%	0.47%	0.59%	1.54%
Payout Ratio	67.17%	37.37%	25.50%	30.07%	53.30%	71.47%
Buyback Yield / Dilution	-2.94%	-7.33%	0.50%	-3.00%	-2.16%	-0.88%
Total Shareholder Return	0.54%	-5.19%	1.50%	-2.53%	-1.57%	0.66%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.